The medical technology industry is facing new challenges, including unstable public policy, increased regulation, a financial downturn and a changing customer base, according to Ernst and Young's 2011 "Pulse of the Industry" report.
The report found that venture capital investment fell 13 percent from 2009-2010, and venture funding fell 15 percent. Meanwhile, IPO activity increased in 2010 with nine medtech companies in the U.S. and Europe completing an IPO. Just two companies did so in 2009. The value of mergers and acquisitions also increased to $30.6 billion in 2010 from a historic low of $15.7 billion in 2009.
Related Articles about the Medtech Industry:
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
FDA, CMS Launch Pilot Program for Voluntary Review of Innovative Devices
Survey: Venture Capitalists Moving Away from Medical Device and Pharmaceutical Companies
The report found that venture capital investment fell 13 percent from 2009-2010, and venture funding fell 15 percent. Meanwhile, IPO activity increased in 2010 with nine medtech companies in the U.S. and Europe completing an IPO. Just two companies did so in 2009. The value of mergers and acquisitions also increased to $30.6 billion in 2010 from a historic low of $15.7 billion in 2009.
Related Articles about the Medtech Industry:
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
FDA, CMS Launch Pilot Program for Voluntary Review of Innovative Devices
Survey: Venture Capitalists Moving Away from Medical Device and Pharmaceutical Companies